Chemical Compound Review:
celiprolol 3-[3-ethanoyl-4-[2-hydroxy-3- (tert...
Synonyms:
Celectol, Celiprololum, CHEMBL27810, SureCN49415, AGN-PC-008H1D, ...
- Effect of beta-adrenergic blockade on exercise performance in patients with chronic atrial fibrillation. Atwood, J.E., Sullivan, M., Forbes, S., Myers, J., Pewen, W., Olson, H.G., Froelicher, V.F. J. Am. Coll. Cardiol. (1987)
- Effects of celiprolol on cardiovascular reactivity to laboratory stressors in patients with hypertension. Cardillo, C., Degen, C., De Felice, F., Folli, G. Clin. Pharmacol. Ther. (1992)
- Acute haemodynamic profile of celiprolol in patients with coronary heart disease and hypertension: a double-blind comparison with metoprolol. Heublein, B., Modersohn, D., Franz, N., Panzner, B. Eur. Heart J. (1991)
- Celiprolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties and its therapeutic use in hypertension and angina pectoris. Riddell, J.G., Shanks, R.G., Brogden, R.N. Drugs (1987)
- Effect of celiprolol treatment in hypertensive patients with sleep apnea. Planès, C., Foucher, A., Leroy, M., Dartois, N., Juste, K., Baillart, O., Raffestin, B. Sleep. (1999)
- Effects of selected beta-adrenergic blocking agents on sleep stages in spontaneously hypertensive rats. Ongini, E., Milani, S., Marzanatti, M., Trampus, M., Monopoli, A. J. Pharmacol. Exp. Ther. (1991)
- Quality of life before and during antihypertensive treatment: a comparative study of celiprolol and atenolol. Cleophas, T.J., van der Mey, N., van der Meulen, J., Niemeyer, M.G. International journal of clinical pharmacology and therapeutics. (1996)
- Celiprolol, a beta-adrenoceptor antagonist with vasodilator effect, improves hemodynamic response to catecholamine, spontaneous locomotor activity, and survival in cardiomyopathic hamsters with advanced heart failure. Nakamura, Y., Ryoke, T., Tanaka, N., Ohkusa, T., Matsuzaki, M. J. Cardiovasc. Pharmacol. (1998)
- Influence of chronic exposure to high concentrations of D-glucose and long-term beta-blocker treatment on intracellular calcium concentrations of porcine aortic endothelial cells. Salameh, A., Dhein, S. Diabetes (1998)
- Orange juice substantially reduces the bioavailability of the beta-adrenergic-blocking agent celiprolol. Lilja, J.J., Juntti-Patinen, L., Neuvonen, P.J. Clin. Pharmacol. Ther. (2004)
- Celiprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in cardiovascular disease. Milne, R.J., Buckley, M.M. Drugs (1991)
- Comparison of celiprolol and propranolol in stable angina pectoris. Celiprolol International Angina Study Group. Frishman, W.H., Heiman, M., Soberman, J., Greenberg, S., Eff, J. Am. J. Cardiol. (1991)
- Distinct pathways for beta-adrenoceptor-induced up-regulation of muscarinic acetylcholine receptors and inhibitory G-protein alpha-subunits in chicken cardiomyocytes. Reithmann, C., Panzner, B., Werdan, K. Naunyn Schmiedebergs Arch. Pharmacol. (1992)
- Effects of celiprolol on plasma renin, aldosterone, norepinephrine and epinephrine in primary hypertension. Kimura, S., DeQuattro, V., Hernandez, P.H., Lee, D.D. Am. J. Cardiol. (1988)
- Comparative effects of metoprolol and celiprolol on cardiac hemodynamics and left ventricular volume at rest and during exercise-induced angina. Silke, B., Verma, S.P., Frais, M.A., Reynolds, G., Taylor, S.H. Clin. Pharmacol. Ther. (1986)
- Lipid effects of celiprolol, a new cardioselective beta-blocker, versus propranolol. Sirtori, C.R., Johnson, B., Vaccarino, V., Montanari, G., Cremoncini, M., Gianfranceschi, G., Sirtori, M., Dujovne, C.A. Clin. Pharmacol. Ther. (1989)
- Cardiovascular mass and ventricular function after celiprolol in Wistar-Kyoto and spontaneously hypertensive rats. Horinaka, S., Frohlich, E.D. Cardiovasc. Res. (1992)
- Transport of celiprolol across human intestinal epithelial (Caco-2) cells: mediation of secretion by multiple transporters including P-glycoprotein. Karlsson, J., Kuo, S.M., Ziemniak, J., Artursson, P. Br. J. Pharmacol. (1993)
- Release of endothelial nitric oxide in coronary arteries by celiprolol, a beta(1)-adrenoceptor antagonist: possible clinical relevance. Noda, K., Oka, M., Ma, F.H., Kitazawa, S., Ukai, Y., Toda, N. Eur. J. Pharmacol. (2001)
- The central and peripheral hemodynamics of celiprolol. Mancia, G. Am. Heart J. (1988)
- Itraconazole increases but grapefruit juice greatly decreases plasma concentrations of celiprolol. Lilja, J.J., Backman, J.T., Laitila, J., Luurila, H., Neuvonen, P.J. Clin. Pharmacol. Ther. (2003)
- Haemodynamic effects of new beta-blockers with vasodilatory properties in essential hypertension. Tsukiyama, H., Otsuka, K., Horii, M. Drugs (1988)
- Pharmacological actions of the selective and non-selective beta-adrenoceptor antagonists celiprolol, bisoprolol and propranolol on human bronchi. Hauck, R.W., Schulz, C., Emslander, H.P., Böhm, M. Br. J. Pharmacol. (1994)
- CYP3A4, CYP3A5, and MDR1 in human small and large intestinal cell lines suitable for drug transport studies. Engman, H.A., Lennernäs, H., Taipalensuu, J., Otter, C., Leidvik, B., Artursson, P. Journal of pharmaceutical sciences. (2001)
- Celiprolol inhibits mitogen-activated protein kinase and endothelin-1 and transforming growth factor-beta(1) gene in rats. Tsubokou, Y., Kobayashi, N., Mita, S., Yoshida, K., Matsuoka, H. Eur. J. Pharmacol. (2002)
- Comparison of the effect of celiprolol and nifedipine on blood pressure and plasma lipids. van Hoof, R., Desager, J.P., Harvengt, C., Fagard, R., Lijnen, P., Peerenboom, P., Staessen, J., Thijs, L., Van Mieghem, W., Amery, A. J. Cardiovasc. Pharmacol. (1992)
- Celiprolol stimulates endothelial nitric oxide synthase expression and improves myocardial remodeling in deoxycorticosterone acetate-salt hypertensive rats. Kobayashi, N., Mori, Y., Nakano, S., Tsubokou, Y., Shirataki, H., Matsuoka, H. J. Hypertens. (2001)
- Experimental design for enantioselective separation of celiprolol by capillary electrophoresis using sulfated beta-cyclodextrin. Daali, Y., Cherkaoui, S., Christen, P., Veuthey, J.L. Electrophoresis (1999)